Quick Answer
RxSight, Inc. reported Long-Term Debt of $0.00 for fiscal year 2023.
RxSight, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2023 | $0.00 | -100.0% |
| 2022 | $40.17M | +1.0% |
| 2021 | $39.76M | +63.0% |
| 2020 | $24.40M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $0.00 | -100.0% | -100.0% |
| June 30, 2023 | $19.59M | -50.9% | -51.4% |
| March 31, 2023 | $40.31M | +1.1% | +0.3% |
| December 31, 2022 | $40.17M | +1.0% | +0.4% |
| September 30, 2022 | $40.02M | +1.0% | +0.4% |
| June 30, 2022 | $39.88M | +0.9% | -0.0% |
| March 31, 2022 | $39.89M | — | +0.3% |
| December 31, 2021 | $39.76M | +63.0% | +0.3% |
- RxSight, Inc. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- Over the 2020–2023 period, RxSight, Inc.’s long-term debt has declined by 100.0% (from $24.40 million to $0.00).
- The most recent figure is from RxSight, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on February 28, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: